Therapeutic Trial of Modified Levofloxacin (MOLVX) Against Induced Colorectal Aberrant Crypt Foci (Precancerous Tissue) in Mice. (2022). The Iraqi Journal of Veterinary Medicine, 46(2), 53-65. https://doi.org/10.30539/ijvm.v46i2.1554